Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
8(100.0%)
8Total
N/A(8)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT06044688Not ApplicableUnknown

EyeQue VisionCheck 510(k) Clinical Trial

Role: lead

NCT04955379Not ApplicableUnknown

Study in Pediatric Volunteers of a Handheld Device Versus a Standard Diagnostic Device in Ophthalmic Refraction

Role: lead

NCT04820218Not ApplicableCompleted

At-home Testing Refraction Results With Best Corrected Visual Acuity (BCVA) Outcomes in Adults

Role: lead

NCT04693247Not ApplicableUnknown

Handheld Device Compared With a Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction

Role: lead

NCT04693260Not ApplicableCompleted

A Clinical Study to Evaluate the Remote Monitoring of Myopia Patients With the EyeQue Insight

Role: lead

NCT03929588Not ApplicableCompleted

Study of a Hand-held Device Plus Mobile App Versus Standard Eye Care Devices in Measuring Refractive Error of the Eye

Role: lead

NCT04474041Not ApplicableCompleted

Study to Evaluate Visual Acuity Measured With the EyeQue Insight Versus a Standard Eyechart.

Role: lead

NCT03957408Not ApplicableCompleted

Investigational Study of Accommodation Triggering and Control to Allow for the Performance of Refraction Measurements

Role: lead

All 8 trials loaded